Lowenstein represented Tonix Pharmaceuticals Holding Corp. in the transaction. Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) signed an agreement to acquire assets of Healion Bio, Inc., including its...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here